William Sheridan
Chief Medical Officer
Other
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2022 | Biocryst Pharmaceuticals Inc (BCRX) | MBBS Chief Development Officer | $549,171 | $2,658,421 |
| 2021 | Biocryst Pharmaceuticals Inc (BCRX) | MBBS Chief Development Officer | $530,600 | $2,531,231 |
| 2020 | Biocryst Pharmaceuticals Inc (BCRX) | MBBS Chief Development Officer | $515,146 | $2,679,920 |
| 2019 | Biocryst Pharmaceuticals Inc (BCRX) | MBBS Chief Medical Officer | $500,142 | $1,067,183 |
| 2018 | Biocryst Pharmaceuticals Inc (BCRX) | MBBS Chief Medical Officer | $485,574 | $2,349,219 |
| 2017 | Biocryst Pharmaceuticals Inc (BCRX) | Senior Vice President and Chief Medical Officer | $469,143 | $1,808,550 |
Earnings-call appearances
-
Biocryst Pharmaceuticals Inc Q4 FY2025 Earnings Call2026-02-26
Biocryst Pharmaceuticals Inc (BCRX)
-
Biocryst Pharmaceuticals Inc Q3 FY2025 Earnings Call2025-10-14
Biocryst Pharmaceuticals Inc (BCRX)
-
Biocryst Pharmaceuticals Inc Q2 FY2022 Earnings Call2022-08-04
Biocryst Pharmaceuticals Inc (BCRX)
-
Biocryst Pharmaceuticals Inc Q1 FY2021 Earnings Call2021-05-06
Biocryst Pharmaceuticals Inc (BCRX)
-
Biocryst Pharmaceuticals Inc Q3 FY2020 Earnings Call2020-11-05
Biocryst Pharmaceuticals Inc (BCRX)
-
Biocryst Pharmaceuticals Inc Q2 FY2020 Earnings Call2020-08-06
Biocryst Pharmaceuticals Inc (BCRX)
-
Biocryst Pharmaceuticals Inc Q1 FY2020 Earnings Call2020-05-06
Biocryst Pharmaceuticals Inc (BCRX)